IP Library Granted Patent US 7,989,091
Granted Patent B2
US 7,989,091 · App. 12/597,651 · Granted Aug 2, 2011

Silanes containing phenothiazine-S-oxide or phenothiazine-S,S-dioxide groups and the use thereof in OLEDs

Assignee: BASF SE
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,989,091
App. No.
12/597,651
Granted
Aug 2, 2011
Kind
B2
Abstract

Silanes comprising phenothiazine S-oxide or phenothiazine S,S-dioxide groups, organic light-emitting diodes comprising the inventive silanes, a light-emitting layer comprising at least one inventive silane and at least one triplet emitter, a process for preparing the inventive silanes and the use of the inventive silanes in organic light-emitting diodes, preferably as matrix materials and/or blocker materials for triplet emitters.

Claims (70)

1. A compound of the general formula I

in which

X is SO 2 or SO;

R 1 is in each case independently optionally substituted aryl, optionally substituted heteroaryl or optionally substituted alkyl;

R 2 , R 3 are in each case independently optionally substituted alkyl, optionally substituted aryl, optionally substituted heteroaryl or substituents having donor or acceptor action;

m is 1, 2, 3 or 4;

n is 1 or 2;

o, p are each independently 0, 1, 2, 3 or 4;

L is a bridging group selected from the group consisting of

—CH 2 —(B) j — and optionally substituted heteroarylene;

R 4 , R 5 , R 6 are in each case independently optionally substituted alkyl, optionally substituted aryl, optionally substituted heteroaryl or substituents having donor or acceptor action;

q, r, s are each independently 0, 1, 2, 3 or 4;

B is an alkylene bridge —C k H 2k —CH 2 —, in which one or more nonadjacent CH 2 groups of the —C k H 2k — unit may be replaced by oxygen or NR 7 ;

R 7 is hydrogen or alkyl;

k is 1, 2, 3, 4, 5, 6, 7 or 8; and

j is 0 or 1.

2. The compound according to claim 1 , in which:

X is SO 2 ;

m is 2, 3 or 4;

o, p are each 0, 1 or 2;

L is

 and

q is 0, 1 or 2.

3. The compound according to claim 1 , wherein at least two of the L or R 1 radicals or groups bonded to the Si are aromatic radicals or groups.

4. The compound according to claim 1 , in which:

L is

 and

o, p

and q are each 0.

5. An OLED comprising at least one compound according to claim 1 .

6. An OLED wherein at least one compound according to claim 1 is used as a matrix material and/or a blocker material.

7. The OLED according to claim 6 , wherein the matrix material and/or blocker material is used together with a triplet emitter.

8. A light-emitting layer comprising at least one compound according to claim 1 and at least one triplet emitter.

9. A hole and/or exciton blocker layer comprising at least one compound according to claim 1 .

10. A process for preparing compounds according to claim 1 , comprising:

(i) preparing a phenothiazine derivate (II)

in which

R 2 , R 3 are in each case independently optionally substituted alkyl, optionally substituted aryl, optionally substituted heteroaryl or a radical having donor or acceptor action;

o, p are each independently 0, 1, 2, 3 or 4;

L is a bridging group selected from the group consisting of

—CH 2 —(B) j — and optionally substituted heteroarylene;

R 4 , R 5 , R 6 are in each case independently optionally substituted alkyl, optionally substituted aryl, optionally substituted heteroaryl or substituents having donor or acceptor action;

q, r, s are each independently 0, 1, 2, 3 or 4;

B is an alkylene bridge —C k H 2k —CH 2 —, in which one or more nonadjacent CH 2 groups of the —C k H 2k — unit may be replaced by oxygen or NR 7 ;

R 7 is hydrogen or alkyl;

k is 1, 2, 3, 4, 5, 6, 7 or 8;

j is 0 or 1; and

Y is a halogen selected from the group consisting of F, Cl and Br;

by reacting phenothiazine or a phenothiazine derivate of the formula (III)

in which R 2 , R 3 , o and p are each as defined above

with a bifunctional compound of the formula (IV)

Z-L-Y  (IV)

in which L and Y are each as defined above and

Z is iodine, fluorine, bromine or tosyl;

(ii) preparing phenothiazine derivates of the formula (V)

in which the radicals and indices are each as defined above, and

m is 1, 2, 3 or 4, and

n is 1 or 2,

by reacting the phenothiazine derivate (II) with a haloalkyl/arylsilane of the general formula (VIa) or with an alkoxysilane of the general formula (VIb)

(R 8 ) t Si(Hal) 4-t   (VIa)

(R 8 ) t Si(OR 9 ) 4-t   (VIb)

in which

R 8 is optionally substituted aryl, optionally substituted heteroaryl or optionally substituted alkyl;

Hal is a halogen;

t is 1, 2 or 3; and

R 9 is alkyl, and

(iii) preparing the phenothiazine S-oxide or S,S-dioxide derivatives of the formula (I)

by reacting the phenothiazine derivates of the formula (V) with an oxidizing agent.

11. The method of using compounds according to claim 1 in OLEDs.

12. Stationary visual display units of computers, televisions, printers, kitchen appliances, advertising panels, illuminations, and information panels and mobile visual display units in cellphones, laptops, digital cameras, and vehicles and destination displays on buses and trains and illumination units, comprising at least one organic light-emitting diode according to claim 5 .

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT APPL. NO. 14/901,736 PREVIOUSLY RECORDED AT REEL: 039460 FRAME: 0615. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jun 8, 2017
From: BASF SE
To: UDC IRELAND LIMITED
Reel/Frame 042740/0222 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 25, 2016
From: BASF SE
To: UDC IRELAND LIMITED
Reel/Frame 039460/0615 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 20, 2011
From: LANGER, NICOLLE; KAHLE, KLAUS; LENNARTZ, CHRISTIAN; SCHILDKNECHT, CHRISTIAN; NORD, SIMON; MOLT, OLIVER; FUCHS, EVELYN; RUDOLPH, JENS; WAGENBLAST, GERHARD
To: BASF SE
Reel/Frame 026479/0206 →
Priority Claims (1)
EP 07107055 · Apr 26, 2007 · regional
Continuity (1)
Related Publication 20100187980A1 · Jul 29, 2010